“Media studies explain it being a loophole,” suggests Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s extremely intentional coverage.” Brunner has expressed aggravation regarding how some coverage of your rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medicines or exploration peptides with credentialed operations https://billt409sag3.csublogs.com/profile